|
|
Posted Sunday, May 31, 2009 7:00 pm CDT
|
Posted Sunday, May 31, 2009 7:00 pm CDT
|
Posted Sunday, May 31, 2009 7:00 pm CDT
|
Amgen, CDC Foundation and CDC Partner to Launch 3-Year Initiative to Improve Infection Control in Vulnerable Cancer Patient Population
THOUSAND OAKS, CA., 5/27/2009 /PRNewswire-FirstCall/..]]> Posted Sunday, May 31, 2009 7:37 am CDT
|
Posted Sunday, May 31, 2009 7:37 am CDT
|
Posted Friday, May 29, 2009 7:18 pm CDT
|
Posted Friday, May 29, 2009 7:18 pm CDT
|
Posted Friday, May 29, 2009 7:18 pm CDT
|
Posted Friday, May 29, 2009 7:00 pm CDT
|
Research explores biomarkers as potential predictors of sensitivity to treatment Pfizer announced results from studies evaluating the companys investigational anti-insulin growth factor- type 1 receptor antibody, figitumumab, in patients with non-small cell lung cancer.]]> Posted Friday, May 29, 2009 7:00 pm CDT
|
Posted Friday, May 29, 2009 7:00 pm CDT
|
Posted Friday, May 29, 2009 8:35 am CDT
|
Posted Friday, May 29, 2009 8:35 am CDT
|
Posted Friday, May 29, 2009 8:35 am CDT
|
Posted Friday, May 29, 2009 8:35 am CDT
|
Posted Friday, May 29, 2009 8:35 am CDT
|
Posted Friday, May 29, 2009 7:54 am CDT
|
Posted Friday, May 29, 2009 6:01 am CDT
|
Posted Friday, May 29, 2009 5:09 am CDT
|
Posted Friday, May 29, 2009 4:46 am CDT
|
|